Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Prokidney (PROK) Invested Capital (2022 - 2025)

Prokidney (PROK) has disclosed Invested Capital for 4 consecutive years, with -$1.0 billion as the latest value for Q3 2025.

  • On a quarterly basis, Invested Capital fell 2.89% to -$1.0 billion in Q3 2025 year-over-year; TTM through Sep 2025 was -$1.0 billion, a 2.89% decrease, with the full-year FY2024 number at -$995.0 million, up 9.83% from a year prior.
  • Invested Capital was -$1.0 billion for Q3 2025 at Prokidney, down from -$1.0 billion in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $20.2 million in Q1 2022 to a low of -$1.6 billion in Q1 2023.
  • A 4-year average of -$955.9 million and a median of -$1.0 billion in 2025 define the central range for Invested Capital.
  • Peak YoY movement for Invested Capital: crashed 20080.61% in 2023, then soared 31.56% in 2024.
  • Prokidney's Invested Capital stood at -$1.1 billion in 2022, then fell by 0.62% to -$1.1 billion in 2023, then grew by 9.83% to -$995.0 million in 2024, then fell by 1.31% to -$1.0 billion in 2025.
  • Per Business Quant, the three most recent readings for PROK's Invested Capital are -$1.0 billion (Q3 2025), -$1.0 billion (Q2 2025), and -$998.6 million (Q1 2025).